Development of Hemolytic Anemia in a Nivolumab-Treated Patient with Refractory Metastatic Squamous Cell Skin Cancer and Chronic Lymphatic Leukemia

Management of patients with metastatic squamous cell skin cancer, refractory to initial therapy with standard chemotherapy and radiation protocols, remains difficult with poor overall prognosis and limited therapeutic options. Recently, promising response rates with nivolumab, a programmed death rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwab, K.S., Heine, A., Weimann, T., Kristiansen, G., Brossart, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939691/
https://www.ncbi.nlm.nih.gov/pubmed/27462240
http://dx.doi.org/10.1159/000447508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939691/
https://www.ncbi.nlm.nih.gov/pubmed/27462240
http://dx.doi.org/10.1159/000447508

Ejemplares similares